AU Stock MarketDetailed Quotes
ACL Australian Clinical Labs Ltd
- 3.500
- +0.030+0.86%
20min DelayMarket Closed Nov 22 16:00 AET
704.82MMarket Cap29.17P/E (Static)
3.530High3.440Low284.11KVolume3.440Open3.470Pre Close997.93KTurnover3.85552wk High0.16%Turnover Ratio201.38MShares2.08152wk Low0.12EPS TTM606.89MFloat Cap5.250Historical High29.17P/E (Static)173.40MShs Float2.081Historical Low0.12EPS LYR2.59%Amplitude0.10Dividend TTM3.97P/B1Lot Size2.86%Div YieldTTM
Australian Clinical Labs Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | |
|---|---|---|---|---|
| Operating cash flow (direct method) | ||||
| Cash income from operating activities | -3.35%694.68M | -27.42%718.73M | 49.59%990.24M | 661.97M |
| Revenue from customers | -3.35%694.68M | -27.42%718.73M | 49.59%990.24M | --661.97M |
| Cash paid | 6.39%-508.76M | 13.17%-543.47M | -39.03%-625.93M | -450.22M |
| Payments to suppliers for goods and services | 6.39%-508.76M | 13.17%-543.47M | -39.03%-625.93M | ---450.22M |
| Direct interest paid | -20.41%-16.67M | -21.55%-13.85M | 71.08%-11.39M | ---39.39M |
| Direct interest received | 175.27%501K | 304.44%182K | -40.00%45K | --75K |
| Direct tax refund paid | 43.29%-10.16M | 74.00%-17.91M | -271.00%-68.87M | ---18.56M |
| Operating cash flow | 11.07%159.59M | -49.42%143.68M | 84.64%284.09M | --153.86M |
| Investing cash flow | ||||
| Cash flow from continuing investing activities | 40.51%-7.25M | 83.09%-12.18M | -1,085.70%-72.04M | -6.08M |
| Net PPE purchase and sale | 7.73%-6.18M | 68.07%-6.7M | -123.32%-20.98M | ---9.39M |
| Net business purchase and sale | ---1.07M | ---- | ---- | ---- |
| Net investment purchase and sale | ---- | ---- | ---- | --1.07M |
| Net other investing changes | ---- | 89.26%-5.48M | -2,367.50%-51.06M | --2.25M |
| Cash from discontinued investing activities | ||||
| Investing cash flow | 40.51%-7.25M | 83.09%-12.18M | -1,085.70%-72.04M | ---6.08M |
| Financing cash flow | ||||
| Cash flow from continuing financing activities | -5.99%-146.14M | 37.59%-137.88M | -49.90%-220.91M | -147.37M |
| Net issuance payments of debt | -116.67%-11M | 166.00%66M | -292.27%-100M | --52.01M |
| Net common stock issuance | -95.51%-1.74M | 81.98%-891K | -103.38%-4.94M | --146.25M |
| Cash dividends paid | 79.01%-20.34M | -299.03%-96.88M | 42.19%-24.28M | ---42M |
| Net other financing activities | -6.55%-113.06M | -15.73%-106.11M | 69.80%-91.69M | ---303.63M |
| Cash from discontinued financing activities | ||||
| Financing cash flow | -5.99%-146.14M | 37.59%-137.88M | -49.90%-220.91M | ---147.37M |
| Net cash flow | ||||
| Beginning cash position | -24.33%19.96M | -25.15%26.37M | 1.10%35.23M | --34.85M |
| Current changes in cash | 197.32%6.21M | 28.07%-6.38M | -2,221.05%-8.87M | --418K |
| Effect of exchange rate changes | 37.50%-25K | -900.00%-40K | 114.71%5K | ---34K |
| End cash Position | 30.97%26.14M | -24.33%19.96M | -25.15%26.37M | --35.23M |
| Free cash from | 11.95%153.09M | -47.97%136.75M | 82.07%262.84M | --144.36M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data